Exhaled NO as a Biomarker of Gestational OSA and Persistence Postpartum

Completed

Conditions studied: Pregnancy, OSA

In brief

This study will evaluate the presence or absence of Obstructive Sleep Apnea (OSA) in the third trimester of pregnancy and again postpartum.

Key facts

Study ID

NCT02100943

Run by

Wake Forest University Health Sciences

People needed

76

Starts

2014-03-01

Expected to finish

2016-11-14

Last updated by the study team

2017-04-20

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Female (> or equal 18 year of age)
• Pregnant between 32 0/7 prior to 35 6/7 weeks gestation
• Anticipated delivery at Forsyth Medical Center: Winston Salem, North Carolina

You may not qualify if…

• Illicit drug/Alcohol abuse
• Current treatment for obstructive sleep apnea
• Age <18 years
• Inability to speak/read English proficiently enough to give informed consent
• Usage of alpha blockers or short acting nitrates
• Permanent pacemaker
• Sustained non-sinus cardiac arrhythmias

Where it is running

• Wake Forest School of Medicine, Forsyth Medical Center — Winston-Salem, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.